Delivery Order SPE2DB22D2103-SPE2DB25FR9TS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,082.99 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen injectors on July 24, 2025. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a routine pharmaceutical procurement for military healthcare needs. The contract was competitively awarded without set-aside designation and specifies performance at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,644.62 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on July 25, 2025, with a completion date of July 28, 2025. This is a firm fixed-price, non-competitive delivery order with no set-aside designation, issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical procurement supporting the federal government's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $54,083.66 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 12, 2025. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,193.99 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injectors, with an ultimate completion date of August 12, 2025. This competitive award was issued on August 11, 2025, under a firm fixed price contract type with no set-aside designation. The performance location is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors with a completion date of August 19, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,720.90 on July 28, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $6,044.24 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors (0.5 ml). The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The contract specifies a completion date of July 31, 2025, and lists the place of performance as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,613.98 on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of September 8, 2025. The product will be performed and sourced from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,888.99 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and represents a continuation of the company's critical role as a pharmaceutical supplier to federal military and healthcare systems. The place of performance...
- The Defense Logistics Agency awarded a $13,618.11 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectors on September 12, 2025, with a completion date of September 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9TSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $111,508.90 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors on September 5, 2025, with completion expected by September 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract covers pharmaceutical supply for federal medical procurement needs, particularly supporting military and veteran healthcare systems under DLA's Medical Supply Chain operations. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. AmerisourceBergen's track record of competitive awards across multiple therapeutic domains demonstrates its established capability to fulfill federal medical supply requirements efficiently and at firm fixed prices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $111.5k | 9/5/25 |